Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 185.74M | 192.44M | 219.83M | 241.86M | 259.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 185.74M | 192.44M | 219.83M | 241.86M | 259.19M |
| Cost of Revenue | 150.05M | 151.90M | 152.71M | 151.67M | 150.88M |
| Gross Profit | 35.69M | 40.54M | 67.12M | 90.19M | 108.31M |
| SG&A Expenses | 143.92M | 154.78M | 158.47M | 160.45M | 161.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 311.37M | 324.85M | 330.22M | 331.19M | 331.87M |
| Operating Income | -125.63M | -132.42M | -110.39M | -89.34M | -72.68M |
| Income Before Tax | -234.97M | -218.04M | -345.03M | -291.76M | -261.48M |
| Income Tax Expenses | -4.21M | -4.23M | -3.82M | -1.97M | -1.86M |
| Earnings from Continuing Operations | -230.76 | -213.81 | -341.21 | -289.80 | -259.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 99.99M | 92.82M | 148.70M | 127.08M | 114.78M |
| Net Income | -130.77M | -121.00M | -192.52M | -162.71M | -144.85M |
| EBIT | -125.63M | -132.42M | -110.39M | -89.34M | -72.68M |
| EBITDA | -74.12M | -80.98M | -60.20M | -39.89M | -24.30M |
| EPS Basic | -0.91 | -0.84 | -1.35 | -1.15 | -1.03 |
| Normalized Basic EPS | 0.06 | -0.02 | 0.46 | 0.40 | 0.39 |
| EPS Diluted | -0.91 | -0.84 | -1.35 | -1.15 | -1.03 |
| Normalized Diluted EPS | 0.06 | -0.02 | 0.46 | 0.40 | 0.39 |
| Average Basic Shares Outstanding | 577.42M | 574.16M | 571.03M | 562.63M | 551.54M |
| Average Diluted Shares Outstanding | 577.42M | 574.16M | 571.03M | 562.63M | 551.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |